41 to 50 of 266 Results
ZIP Archive - 5.0 MB -
MD5: 0eec78a59ca6e8c5d09d8ce93d1cb719
|
ZIP Archive - 70.1 MB -
MD5: 404dac76d27e87a79bbb4ec244853d5a
|
Adobe PDF - 1.1 MB -
MD5: 7b159aef8d66d001ad795002320f25d3
|
MS Excel Spreadsheet - 87.9 KB -
MD5: 1fb2741baf51bcc667e264aeb1519626
|
Plain Text - 16.5 KB -
MD5: e1af8763daba533eb1d77153888354bd
|
R Notebook - 168.5 KB -
MD5: 93962fc71c89f1c3c366b883f6a990d6
|
Feb 1, 2024
Warimwe, George M.; Kimathi, Derick; Cheruiyot, Stanley; Bejon, Philip, 2024, "Data for: Non- inferiority fractional-doses trial for yellow fever vaccine (NIFTY Trial)", https://doi.org/10.7910/DVN/YBRX8I, Harvard Dataverse, V2, UNF:6:Zw1UGT8lKZDq60RW8Com4Q== [fileUNF]
The NIFTY trial sought to determine whether reducing the dosage of the vaccine can provide the same protection to the standard dosage given in Kenyan and Ugandan adults and children. The trial is registered at ClinicalTrials.gov. ID: NCT04059471. This dataset relates to a trial to determine the safety and immune response elicited by the reduced dos... |
Feb 1, 2024 -
Data for: Non- inferiority fractional-doses trial for yellow fever vaccine (NIFTY Trial)
ZIP Archive - 9.2 MB -
MD5: fb8dbd2b0b5297f2ecd4de48b2ee986f
|
Feb 1, 2024 -
Data for: Non- inferiority fractional-doses trial for yellow fever vaccine (NIFTY Trial)
Adobe PDF - 909.3 KB -
MD5: e705ce387c5da9d0a5d7eaecae1d7cee
|
Jan 31, 2024 -
Data for: Non- inferiority fractional-doses trial for yellow fever vaccine (NIFTY Trial)
Tabular Data - 290.8 KB - 246 Variables, 480 Observations - UNF:6:+xQFgnvtlZSupTZOsOcHrA==
|